Alcohol cancer risk message study
Part of Cancer clinical trials.
This study tests messages about alcohol and cancer risk. It might help you understand how drinking affects your health if you have certain cancers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 21 years old or older
- You live in the United States
- You can read and speak English
- You have been diagnosed with cancer of the mouth, throat, voice box, liver, colon, rectum, or breast
- You have had at least 1 alcoholic drink in the past 30 days
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses eye-tracking technology to see how people pay attention to alcohol warning labels. It may help improve how warnings are designed to be more effective.
This study tests different health messages about alcohol and cancer risk to see which ones are most effective, aiming to help people make informed choices.
This study looks at how different messages about alcohol and breast cancer risk affect young women. Researchers want to find the best way to communicate this risk to help women make informed choices.
This study tests different warning labels on alcohol to see which ones are most effective. You may participate if you are an adult living in the U.S. and have either drunk alcohol recently or not.
This study looks at how to explain the benefits and risks of new cancer drugs in a way that is easier to understand. It helps researchers learn how to communicate better with patients like you.
This study is testing a digital program that helps women understand how alcohol affects their risk of breast cancer. If you are a woman 40+ who drinks regularly, this program may help you make more informed health choices during your next screening visit.
Hear when a new Alcohol trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.